(Q24248015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Excitatory amino acid antagonists for acute stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

K R Lees

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

CD001244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients: a dose-ranging study

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Dose optimization of intravenous magnesium sulfate after acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Considerations in the design of clinical trials of neuroprotective therapy in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Calcium antagonists for ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Clinical experience with excitatory amino acid antagonist drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Neuroprotection for acute stroke: making clinical trials work

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Tirilazad mesylate in acute ischemic stroke: A systematic review. Tirilazad International Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators.

21 January 2018

1 reference

12 December 2020

Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide.

1 reference

12 December 2020

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

12 December 2020

AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels

1 reference

12 December 2020

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

1 reference

12 December 2020

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial

1 reference

12 December 2020

Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial

1 reference

12 December 2020

Cardiovascular safety of lubeluzole (Prosynap(R)) in patients with ischemic stroke.

1 reference

12 December 2020

Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole

1 reference

12 December 2020

Treatment of experimental focal ischemia in rats with lubeluzole

1 reference

12 December 2020

FUNCTIONAL EVALUATION: THE BARTHEL INDEX

1 reference

12 December 2020

Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke

1 reference

12 December 2020

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators

1 reference

12 December 2020

Diffusion-weighted MRI of infarct growth in a rat photochemical stroke model: effect of lubeluzole

1 reference

12 December 2020

Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat

1 reference

12 December 2020

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

1 reference

12 December 2020

Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial

1 reference

12 December 2020

Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion

1 reference

12 December 2020

ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma

1 reference

12 December 2020

Dose escalation safety and tolerance study of the competitive NMDA antagonist selfotel (CGS 19755) in neurosurgery patients.

1 reference

12 December 2020

Development of the NMDA ion-channel blocker, aptiganel hydrochloride, as a neuroprotective agent for acute CNS injury.

1 reference

12 December 2020

Magnesium in stroke treatment.

1 reference

12 December 2020

Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.

1 reference

12 December 2020

Systemic and Cerebral Hemodynamic Responses to the Noncompetitive N-Methyl-D-Aspartate (NMDA) Antagonist CNS 1102

1 reference

12 December 2020

Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke

1 reference

12 December 2020

Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.

1 reference

12 December 2020

Safety and tolerability of 619C89 after acute stroke

1 reference

12 December 2020

Lubeluzole for acute ischaemic stroke

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers.

1 reference

12 December 2020

Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model.

1 reference

12 December 2020

Lubeluzole blocks increases in extracellular glutamate and taurine in the peri-infarct zone in rats.

1 reference

12 December 2020

Pharmacokinetics of 619C89, a novel neuronal sodium channel inhibitor, in acute stroke patients after loading and discrete maintenance infusions

1 reference

12 December 2020

Phase II studies of the glycine antagonist GV150526 in acute stroke : the North American experience. The North American Glycine Antagonist in Neuroprotection (GAIN) Investigators

1 reference

12 December 2020

Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial

1 reference

12 December 2020

Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study.

1 reference

12 December 2020

YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.

1 reference

12 December 2020

The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging

1 reference

12 December 2020

Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design

1 reference

12 December 2020

Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001244

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD001244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12917902%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference